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Abstract: A three year old female Rottweiler dog was presented with clinical signs of chronic diarrhoea, severe weight 
loss and sporadic vomiting. Histopathology revealed intestinal lymphangiectasia with lipogranulomatous lymphangitis. 
Intestinal lymphangiectasia represents a pathological dilatation of the intestinal lymph vessels and is the most common 
cause of protein-losing enteropathy in the dog. This paper reports a clinical case with a short review of literature..    
 
Resumo: Uma cadela, fêmea, de raça Rottweiller de três anos de idade apresentou-se com sinais clínicos de diarreira 
crónica, perda de peso grave e vómito esporádico. A histopatologia revelou uma linfangiectasia intestinal com 
linfangite lipogranulomatosa. A linfangiectasia intestinal consiste numa dilatação patológica dos vasos linfáticos 
intestinais, sendo a causa mais frequente de enteropatia com perda de proteína no cão. Este trabalho consiste na 
apresentação do caso clínico e numa breve revisão da literatura 
 
INTRODUCTION 
 
Intestinal lymphangiectasia (IL) is an 
uncommon disease but an important cause 
of protein-losing enteropathy in the dog. The 
major morphological abnormality that 
characterizes this disease is marked dilation 
of intestinal lymphatic vessels in the 
mucosa, submucosa and serosa (Finco et al., 
1973; Melzer & Sellon, 2002; Batt & Hall, 
1989). 
It has been recognized as a clinical entity in 
humans since 1961 and has been first 
described in dogs in 1968 (Waldmann, 
1966; Campbell et al., 1968; Finco et al., 
1973; Mattheeuws, 1974). 
The clinical signs of IL can be quite 
variable. Many dogs with IL exhibit 
nonspecific signs, such as anorexia or 
lethargy. Diarrhoea is one of the most 
consistent clinical signs associated to this 
disease, although not seen in all patients 
(Griffiths et al., 1982; Melzer & Sellon, 
2002). Effusions or oedema, more often pure 
transudates effusions, may develop when 
serum albumin concentrations fall below 1.5 
g/dl (Melzer & Sellon, 2002). 
Laboratory abnormalities can support the IL 
diagnosis; however they are neither specific 
nor pathognomonic of the disease (Kull et 
al., 2001). 
 
 
CASE DESCRIPTION 
A three year old female Rottweiler, 45 kg 
b.w. was admitted for consultation at the 
teaching hospital of the Veterinary 
University (FMV-ULHT) with a two months 
history of chronic diarrhoea, severe weight 
loss and sporadic vomiting. The owner 
described large amounts of brown watery 
stools, with no mucus or fresh blood, 3 to 4 
times a day and no tenesmus. 
The dog was eating well, was alert and 
responsive, although he had lost 13 kg in 
two months.   
Previous exams performed by the referring 
vet revealed hypoproteinemia (3.2 g/dL, 
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reference range: 5.0 to 7.2 g/dL), 
lymphocytosis (5.7x109/L, reference range: 
0.8 to 5.1x109/L) and thrombocytopaenia 
(84x109/L, reference range: 117 to 
460x109/L). The diarrhoea did not respond 
to various antibiotic treatments or dietary 
management (hypoallergenic diet) and there 
was no complete improvement of symptoms.  
 
On admission, clinical examination revealed 
mild abdominal discomfort, distended 
abdomen and emaciation. 
Blood, biochemical profile, abdominal 
ultrasound and radiography were performed. 
 
Hematological findings showed mild 
lymphocytosis (5.7x109/L, reference 
range:0.8 to 5.1x109/L) and 
thrombocytopaenia (84x109/L, reference 
range:117 to 460x109/L). 
Biochemical profile showed moderate 
hypoproteinemia (4.2 g/dL, reference range: 
5.0 to 7.2 g/dL) with hypoalbuminemia (1.7 
g/dL, reference range: 2.3 to 4.0 g/dL).  
Cholesterol level was border line, 112 
mg/dL (reference range: 110 to 321 mg/dL). 
Liver was apparently normal with alanine 
aminotransferase of 50 u/l (reference range: 
47 to 254 u/l). 
Urinalysis was within normal limits.  
Radiographic exam was unremarkable 
except for a slight splenomegaly (figure 1). 
 
        
 
Figure 1 – Lateral abdominal radiograph showing 
slight splenomegaly 
 
Abdominal ultrasound examination revealed 
an increase of the small intestinal wall (8 
mm), with normal layering, mild 
hipermotility and preserved function. Some 
intestinal segments had dilated lumen with 
anechoic content.  It was identifiedmild 
splenomegaly with normal echogenicity and 
architecture, without focal or diffuse 
abnormalities. The colon had some faecal 
content and the mesenteric lymphnodes 
were normal (figure 2). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 – Transverse ultrasonogram of some 
sections of small intestine illustrating increase of the 
wall with normal layering. 
 
At that time, the animal was medicated with 
metronidazol at a dosage of 15mg/kg, twice 
daily (Flagyl®, Sanofi-Aventis) and 
amoxicilin potenciated with clavulanic acid 
at a dosage of 12,5mg/kg, twice daily 
(Synulox®, Pfizer). Pancreatic enzymes 
were prescribed at a dosage of one capsule 
twice daily, with meals (Kreon®, 
Solvayfarma) as well as an ultra-low-fat diet 
supplemented with peanut oil. Cimetidine at 
a dosage of 5mg/kg, twice a day (Tagamet®, 
Smith Kline & French) and Vitamin B12 at 
a dosage of 1000 µg/dog once a week, for 
six weeks, (OHB12 5000 µg, Jaba 
Recordati).  
Clinical and imaging findings were 
compatible with the following differential 
diagnosis of protein-losing enteropathy (ex: 
intestinal lymphangiectasia) and severe 
chronic enteritis (ex: severe small intestinal 
IBD- inflammatory bowel disease –, with 
SIBO- small intestinal bacterial overgrowth, 
acute ulcerative enteritis and small intestinal 
neoplasia (ex: alimentary lymphoma). 
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An exploratory celiotomy was 
recommended in order to collect intestinal 
and stomach full thickness biopsies.  
To minimize the anaesthetic risk and post 
operative complications, a plasma 
transfusion was done to increase short-term 
the albumin level.  
During the surgery, the presence of multiple 
small white nodules along ectasic lymphatic 
vessels on the serosal surface of the small 
intestine was evident. Furthermore, 
prominent mesenteric lymph vessels were 
distended with thick and chalky white paste 
(figure 3). Liver surface was irregular with 
visible alterations and a liver guillotine type 
biopsy was performed. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 – Intraoperative image of distended and 
prominent mesenteric lymph vessels. Note the focal 
whitish points enlargements corresponding to 
lipogranulomas on the anti-mesenteric serosal surface. 
 
Histopathological findings revealed a thicker 
intestinal mucosa due to lymphatic vessels 
ectasia and lymphoplasmacytic infiltrate in 
the lamina propria. The submucosa showed 
dilated lymphatic vessels, and in the 
subserosa, several lipogranulomes composed 
of foamy machrophages, were observed on 
the periphery of ruptured lymphatic vessels. 
The liver biopsy showed dilated lymphatic 
vessels in the periportal area, and mild 
hepatocyte vacuolar degeneration. 
The histopathological diagnosis was 
intestinal lymphangiectasia with 
lipogranulomatous lymphangitis and 
hepatic-lymphatic congestion with vacuolar 
degeneration. 
  
 
DISCUSSION 
 
 IL is an uncommon disease in the general 
canine population, but is one of the most 
common causes of gastrointestinal protein 
loss. Its inheritance is still unknown but 
breeds with a higher incidence of IL due to 
inflammatory diseases include Basenjis, 
Soft-coated Wheaten Terriers, and 
Lundehunds (Melzer & Sellon, 2002; 
Littman et al., 2000; Landsverk & Gamlem, 
1984). 
This disease can be primary or secondary 
and, in contrast to human IL, canine 
congenital IL is considered less common 
than acquired IL (Finco et al., 1973; Melzer 
& Sellon, 2002). 
Acquired IL is mainly idiopathic, but can 
also be recognized most frequently due to 
inflammatory processes that block lymphatic 
vessels and lymph flow. Other causes of 
increased pressure in lymph vessels include 
portal hypertension resulting from cirrhosis 
or heart disease (i.e., right-sided heart 
failure, pericardial effusion and pericarditis). 
Although, less frequently, we can also see 
cases with associated tumours of the 
intestinal wall, mesentery or even metastatic 
tumours (Melzer & Sellon, 2002; Louvet & 
Denis, 2004). 
Congenital IL, rarely reported, is caused by 
abnormally formed lymphatic vessels (Fogle 
& Bissett, 2007). 
The diagnosis of IL in dogs can be 
challenging. Clinical signs of IL can be 
highly variable, as many dogs with IL 
exhibit nonspecific signs such as lethargy or 
anorexia; however, diarrhoea remains the 
most common clinical feature, especially 
small bowel diarrhoea (Fogle & Bissett, 
2007). 
Ascites, oedema, and hydrothorax are 
common in dogs with IL, mainly found due 
to decreased oncotic pressure secondary to 
hypoproteinemia, (especially 
hypoalbuminemia). In some dogs, clinical 
signs of thromboembolic disease, such as 
tachypnea and dyspnea due to pulmonary 
thromboembolism, may develop (Melzer & 
Sellon, 2002). 
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As previously described, laboratory findings 
in dogs with IL may suggest intestinal loss 
of lymph; however, they are not specific for 
a definitive diagnosis. Lymphopenia is the 
most frequent change supportive of IL, 
although in this case it was not observed. 
Anaemia and neutrophilic leukocytosis, (due 
to chronic inflammation) may be present in 
some dogs, however, not verified in this one. 
In this case, hypoalbuminemia was verified 
and this is the most consistent laboratory 
abnormality reported in canine IL. In some 
cases it can even be noticed pan-
hypoproteinemia (Melzer & Sellon, 2002; 
Burns, 1982).  
Hypocholesterolemia is another frequent 
biochemical alteration seen in canine IL 
although, was also absent in this case.  
Other biochemical abnormalities reported 
include hypocalcemia secondary to overall 
loss of bound calcium resulting from 
hypoalbuminemia, and secondary to poor 
absorption as also vitamin D from the gut 
and by the lipogranuloma formation within 
the lymph vessels. Total serum calcium 
level is often decreased as an artefact of low 
serum albumin concentration (Melzer & 
Sellon, 2002; Burns, 1982; Fogle & Bissett, 
2007; Mellanby et al., 2005). 
Thrombocytopenia, although unusual in IL 
cases, was seen in this dog. Some authors 
suggest this finding as a complication of the 
disease, such as thromboembolism or 
disseminated intravascular coagulation, 
however, no signs of these diseases were 
observed (Melzer & Sellon, 2002). 
The IL diagnosis is only confirmed by 
intestinal biopsy specimens (Kull et al., 
2001). 
In this case surgical biopsy samples were 
performed by laparotomy due to the 
advantages of obtaining full-thickness 
lymphatic architecture and less disruption of 
the normal structure when compared to 
samples collected by endoscopy (Fogle & 
Bissett, 2007). 
The whitish spots observed in the small 
intestinal serosal surface and prominent 
dilated mesenteric lymph vessels 
corresponded to lipogranulomatous 
lymphangitis on histopathological 
examination. Not all cases of canine 
intestinal lymphangiectasia show this type 
of lesions and it is believed that this 
lipogranulomes result from an inflammatory 
foreign body type reaction. This 
inflammatory reaction is  rich with 
macrophages that appear not only due to the 
extravasation of lipid content, through 
dilated wall or ruptured lymph vessels, but 
also secondary to stagnated chylous and fat 
in perilymphatic tissues (Langley-Hobbs, 
1993). 
Increased activities of liver enzyme and 
vacuolar changes in hepatocytes have been 
described in dogs with IL (Finco et al., 
1973; Fogle & Bissett, 2007). In this case, 
although there were no changes in 
biochemical liver function, histological 
appearance of the liver was consistent with 
lymphatic congestion and vacuolar 
degeneration.   
Urinalysis results are important as 
differential diagnosis for hypoalbuminemia 
secondary to renal protein lost (Melzer & 
Sellon, 2002). In this dog urinalysis results 
were unremarkable as in all IL cases. 
The gold of therapy in secondary IL cases 
includes treatment of underlying disease. In 
primary lymphangiectasia cases, treatment is 
basically supportive and symptomatic. 
Affected patients should have dietary 
modification with specific nutritional 
treatment, including low-fat food and 
supplements with adequate amounts of 
essential fatty acids, a reduction in long-
chain triglycerides, because they stimulate 
the loss of lymph to the gastrointestinal 
lumen by chylomicron formation.  
Long-chain triglycerides are not advisable in 
IL affected animals. Although there is some 
controversy about the mechanism of 
absorption for medium-chain triglycerides 
(MCTs), it is felt that MCTs can provide 
some of the favourable aspects helpful in 
recovering the patient’s body condition, 
without stimulating lymph loss (Peterson & 
Willard, 2003; Melzer & Sellon, 2002; 
Brooks, 2005). 
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 To ensure the success of nutritional 
treatment is also really important to choose 
high-quality and highly-digestible protein 
sources, so that we can minimize protein 
indigestion and reduce the production of 
toxins by bacterial flora. 
Immunosuppressive therapy with 
glucocorticoids may be useful in some 
specific cases, especially when the disease is 
secondary to an inflammatory cause. 
Prednisone at immunosuppressive doses (2 
to 4 mg/kg/day) is commonly used in the 
initial management of many dogs with IL 
and mucosal inflammation.  In patients that 
respond poorly to glucocorticoids or in 
severe cases, azathioprine may be added (1 
to 2 mg/kg or 50 mg/m2 PO q24–48h). In 
this case no glucocorticoids were prescribed. 
Antibiotherapy with metronidazole is also 
indicated not only because of its 
antimicrobial effectiveness, but also by their 
immuno-modulatory capabilities (Pibot et 
al., 2006; Hand & Novotny, 2002; Melzer & 
Sellon, 2002).  
As demonstrated in this case, a favourable 
outcome could be achieved with specific 
dietary management and supportive therapy, 
without glucocorticoid therapy.  
The main goal of treatment is the control of 
clinical signs, without cure. Previous studies 
reported a 2 years survival time after 
diagnosis (Hand & Novotny, 2002; Griffiths 
et al., 1982; Melzer & Sellon, 2002).   
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